Klaus K Orlinger

2PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 24, 2025
The long-lasting expression of recombinant artLCMV following intraperitoneal administration exerts potent antitumor effects on tumor models of peritoneal carcinomatosis.

Celia Gomar, Aline Risson, Leire Arrizabalaga

|Jun 10, 2025
Combining local cytokine delivery and systemic immunization with recombinant artLCMV boosts antitumor efficacy in several preclinical tumor models.

Kimberly Pojar, Diana Reckendorfer, Judith Strauss

Pageof 1

Frequent Collaborators

2 joint publications

Pedro Berraondo

1 joint publications

Kimberly Pojar

1 joint publications

Josipa Raguz

1 joint publications

Henning Lauterbach